Changzheng Li

2.2k total citations
78 papers, 1.4k citations indexed

About

Changzheng Li is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Changzheng Li has authored 78 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 23 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Changzheng Li's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Metal complexes synthesis and properties (6 papers) and RNA modifications and cancer (5 papers). Changzheng Li is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Metal complexes synthesis and properties (6 papers) and RNA modifications and cancer (5 papers). Changzheng Li collaborates with scholars based in China, United States and Australia. Changzheng Li's co-authors include Yun Fu, Yongli Li, Sufeng Zhou, Tengfei Huang, Youxun Liu, Guizhi Yang, Yitao Ou, Cuiping Li, Tian Lan and Yanjie Sun and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Hepatology.

In The Last Decade

Changzheng Li

73 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changzheng Li China 22 719 277 240 223 205 78 1.4k
Changqing Yang China 26 776 1.1× 422 1.5× 201 0.8× 347 1.6× 148 0.7× 92 1.7k
Kesong Peng China 21 730 1.0× 180 0.6× 293 1.2× 199 0.9× 85 0.4× 28 1.3k
Peihua Luo China 28 934 1.3× 190 0.7× 465 1.9× 179 0.8× 300 1.5× 94 1.8k
Aya Naiki‐Ito Japan 25 870 1.2× 279 1.0× 245 1.0× 157 0.7× 283 1.4× 99 1.7k
Antonella Cusimano Italy 22 738 1.0× 221 0.8× 232 1.0× 119 0.5× 70 0.3× 35 1.2k
Antonella Miglietta Italy 22 699 1.0× 277 1.0× 198 0.8× 237 1.1× 67 0.3× 40 1.4k
Xia Zou China 18 770 1.1× 210 0.8× 165 0.7× 155 0.7× 61 0.3× 58 1.2k
Mohamed S. Abdel‐Bakky Egypt 20 670 0.9× 226 0.8× 247 1.0× 112 0.5× 92 0.4× 67 1.5k
Sheng‐Yow Ho Taiwan 21 543 0.8× 185 0.7× 169 0.7× 200 0.9× 156 0.8× 68 1.2k

Countries citing papers authored by Changzheng Li

Since Specialization
Citations

This map shows the geographic impact of Changzheng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changzheng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changzheng Li more than expected).

Fields of papers citing papers by Changzheng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changzheng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changzheng Li. The network helps show where Changzheng Li may publish in the future.

Co-authorship network of co-authors of Changzheng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Changzheng Li. A scholar is included among the top collaborators of Changzheng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changzheng Li. Changzheng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jiapeng, et al.. (2025). Metabolic Engineering of Escherichia coli for Xylitol Production. Fermentation. 11(3). 131–131. 2 indexed citations
2.
Li, Changzheng, Zhenyu Li, Gabriele Siesto, et al.. (2024). Retrospective study of combined pelvic exenteration in the treatment of primary and recurrent pelvic malignant tumors. Journal of Gastrointestinal Oncology. 15(1). 299–311.
3.
Li, Changzheng, Binghuo Wu, Yishan Li, et al.. (2022). Amino acid catabolism regulates hematopoietic stem cell proteostasis via a GCN2-eIF2α axis. Cell stem cell. 29(7). 1119–1134.e7. 59 indexed citations
4.
Li, Yongli, et al.. (2021). The DpdtbA induced EMT inhibition in gastric cancer cell lines was through ferritinophagy-mediated activation of p53 and PHD2/hif-1α pathway. Journal of Inorganic Biochemistry. 218. 111413–111413. 35 indexed citations
5.
Li, Longlong, Hao Li, Yongli Li, et al.. (2021). Ferritinophagy‐Mediated ROS Production Contributed to Proliferation Inhibition, Apoptosis, and Ferroptosis Induction in Action of Mechanism of 2‐Pyridylhydrazone Dithiocarbamate Acetate. Oxidative Medicine and Cellular Longevity. 2021(1). 5594059–5594059. 12 indexed citations
6.
Sun, Yanjie, et al.. (2019). Ferritinophagic Flux Activation in CT26 Cells Contributed to EMT Inhibition Induced by a Novel Iron Chelator, DpdtpA. Oxidative Medicine and Cellular Longevity. 2019. 1–14. 15 indexed citations
7.
Li, Yongli, Tengfei Huang, Yun Fu, et al.. (2019). Antitumor activity of a novel dual functional podophyllotoxin derivative involved PI3K/AKT/mTOR pathway. PLoS ONE. 14(9). e0215886–e0215886. 17 indexed citations
8.
Yang, Yun, Youxun Liu, Rui Guo, et al.. (2018). The novel dithiocarbamate, DpdtC suppresses HER2-overexpressed cancer cells by up-regulating NDRG1 via inactivation of HER2-ERK 1/2 signaling. Scientific Reports. 8(1). 3398–3398. 14 indexed citations
9.
Wang, Yequan, Yongji Zhang, Li Ma, et al.. (2018). Genetic diversity and haplotype structure of 27 Y-STR loci in a Yanbian Korean population from Jilin Province, Northeast China. Legal Medicine. 36. 110–112. 4 indexed citations
10.
Fu, Yun, et al.. (2018). Di‐2‐pyridylhydrazone Dithiocarbamate Butyric Acid Ester Exerted Its Proliferative Inhibition against Gastric Cell via ROS‐Mediated Apoptosis and Autophagy. Oxidative Medicine and Cellular Longevity. 2018(1). 4950705–4950705. 5 indexed citations
11.
Yang, Yun, Rui Guo, Xiaoting Tian, et al.. (2017). Synergistic anti-tumor activity of Nimotuzumab in combination with Trastuzumab in HER2-positive breast cancer. Biochemical and Biophysical Research Communications. 489(4). 523–527. 19 indexed citations
12.
Guo, Xiao, Si‐Jia Chen, Changzheng Li, et al.. (2017). Matrix attachment region combinations increase transgene expression in transfected Chinese hamster ovary cells. Scientific Reports. 7(1). 42805–42805. 37 indexed citations
13.
14.
Huang, Tengfei, et al.. (2015). Antitumor activity of a 2-pyridinecarboxaldehyde 2-pyridinecarboxylic acid hydrazone copper complex and the related mechanism. Oncology Reports. 34(3). 1311–1318. 10 indexed citations
15.
16.
Wang, Zhehai, Minmin Li, Jun Guo, et al.. (2014). Clinical significance of UGT1A1 gene polymorphisms on irinotecan-based regimens as the treatment in metastatic colorectal cancer. OncoTargets and Therapy. 7. 1653–1653. 39 indexed citations
17.
Zhou, Yuanping, Junjie Wang, Changzheng Li, et al.. (2013). Simultaneous Expression of Displayed and Secreted Antibodies for Antibody Screen. PLoS ONE. 8(11). e80005–e80005. 8 indexed citations
18.
Zhang, Yanfang, et al.. (2013). A straightforward ninhydrin-based method for collagenase activity and inhibitor screening of collagenase using spectrophotometry. Analytical Biochemistry. 437(1). 46–48. 34 indexed citations
19.
Li, Changzheng, Huiying Li, Sufeng Zhou, et al.. (2009). Polymerase Translocation with Respect to Single-Stranded Nucleic Acid: Looping or Wrapping of Primer around a Poly(A) Polymerase. Structure. 17(5). 680–689. 3 indexed citations
20.
Hu, Guanghui, Akihiro Oguro, Changzheng Li, Paul D. Gershon, & Florante A. Quiocho. (2002). The “Cap-Binding Slot” of an mRNA Cap-Binding Protein:  Quantitative Effects of Aromatic Side Chain Choice in the Double-Stacking Sandwich with Cap,. Biochemistry. 41(24). 7677–7687. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Changqing Yang Breakdown of academic impact, for papers by Kesong Peng Breakdown of academic impact, for papers by Peihua Luo Breakdown of academic impact, for papers by Aya Naiki‐Ito Breakdown of academic impact, for papers by Antonella Cusimano Breakdown of academic impact, for papers by Antonella Miglietta Breakdown of academic impact, for papers by Xia Zou Breakdown of academic impact, for papers by Mohamed S. Abdel‐Bakky Breakdown of academic impact, for papers by Sheng‐Yow Ho
Rankless by CCL
2026